The abstract is read at the publisher; the summary is JClub's.
Morphea and systemic sclerosis are linked to higher overall cancer incidence than the general population, with SIRs of 1.24 and 1.37, respectively.
- Why it matters: Population-level evidence on cancer risk in morphea is limited and conflicting, despite systemic sclerosis being known to carry increased cancer risk.
- What they did: In a Quebec, Canada retrospective cohort (1996–2019; follow-up through December 31, 2020), linked registry data estimated incident cancers and calculated standardized incidence ratios versus general-population rates.
- The result: Solid tumors were elevated in both cohorts (morphea SIR 1.17; SSc SIR 1.21), hematologic cancers were markedly elevated in SSc (SIR 2.40), and younger age showed the highest relative risk.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.